Subsidy Tracker: Industry Summary Page

Major Industry: 
pharmaceuticals
Subsidy Total: 
$3,136,366,702
Number of Awards: 
2,557
Time Period: 

Earliest year of data: 1982. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this industry are for the period since 2011.

Notes: 

The dollar total above adjusts for the fact that there is an overlap between the amounts in one or more Megadeal entries and those of one or more of the other entries. The total includes only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. Dollar totals do not include awards for which no subsidy value is disclosed.


Top 10 Parent CompaniesTotal Subsidy $Number of Awards
Pfizer$374,535,346216
AstraZeneca$335,507,55144
Eli Lilly$285,215,89161
Novo A/S$210,677,93286
Sanofi$177,416,76161
Novartis$173,887,776110
Merck$136,950,97288
Regeneron Pharmaceuticals$93,842,52160
Allergan$89,088,91563
Bristol-Myers Squibb$88,862,84947


Individual Subsidy Records:

Download results as CSV or XML
Company Parent Location Subsidy Source Year Subsidy Valuesort icon Loan/Bailout Value Type of Subsidy
Eli Lilly Eli Lilly Indiana multiple 1999 $214,000,000 MEGADEAL
AstraZeneca AstraZeneca Delaware multiple 1999 $178,000,000 MEGADEAL
Amylin Pharmaceuticals AstraZeneca Ohio multiple 2007 $117,000,000 MEGADEAL
Novo Nordisk Novo A/S North Carolina multiple 2016 $109,900,000 MEGADEAL
Pfizer Pfizer Michigan multiple 2001 $84,200,000 MEGADEAL
Vertex Pharmaceuticals Vertex Pharmaceuticals Massachusetts multiple 2011 $72,000,000 MEGADEAL
Bristol-Myers Squibb Bristol-Myers Squibb Massachusetts state 2006 $67,000,000 MEGADEAL
ACAMBIS INC Sanofi United States federal 2004 $67,000,000 federal grant
Pfizer Pfizer Connecticut multiple 1998 $60,000,000 MEGADEAL
Allergan Sales, LLC Allergan New Jersey state 2016 $58,284,000 tax credit/rebate
Allergan Sales, LLC Allergan New Jersey state 2016 $58,284,000 MEGADEAL
Alexion Pharmaceuticals Alexion Pharmaceuticals Connecticut state 2012 $51,000,000 tax credit/rebate
Biovail Americas Corporation and subsidiaries Bausch Health New Jersey state 2013 $39,502,500 tax credit/rebate
ImClone Systems Corporation Eli Lilly New Jersey state 2008 $32,363,676 grant
Novozymes Blair, Inc. Novo A/S United States federal 2010 $28,401,000 federal allocated tax credit
Alexion Pharmaceuticals, Inc Alexion Pharmaceuticals Connecticut state 2013 $26,000,000 grant/loan hybrid program
AMYRIS, INC. Amyris United States federal 2010 $24,341,409 federal grant
Merck & Co., Inc. Merck North Carolina state 2004 $24,000,000 grant/loan hybrid program
Sanofi-Aventis U.S. LLC and Sanofi-Aventis U.S. In Sanofi New Jersey state 1999 $21,795,200 grant
Perrigo Company Perrigo Michigan state 2013 $21,463,000 property tax abatement
Novo Nordisk Pharmaceutical Industries, Inc. Novo A/S North Carolina state 2015 $21,149,000 grant
Merck, Sharp & Dohme Corp. Merck Pennsylvania state 2011 $19,590,893 tax credit/rebate
Zoetis Inc. and Subsidiaries Zoetis New Jersey state 2012 $19,250,000 grant
Wyeth Holdings Corporation Pfizer North Carolina state 2008 $18,128,934 tax credit/rebate
OSI Pharmaceuticals Astellas Pharma New York state 2010 $15,000,000 grant
XOMA (US) LLC Xoma Corp. United States federal 2005 $15,000,000 federal grant
Allergan Sales, LLC Allergan New Jersey state 2011 $14,906,273 grant
Perrigo Company Perrigo Michigan state 2013 $14,315,000 tax credit/rebate
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals New York local 2014 $13,628,726 tax credit/rebate
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals New York local 2015 $13,628,726 tax credit/rebate
Biogen Idec US Limited Partnership Biogen Idec North Carolina state 2009 $12,564,345 tax credit/rebate
Pharmacia & Upjohn Company Pfizer New Jersey state 1998 $12,500,000 grant
SIGMA-ALDRICH BIOTECHNOLOGY L.P. Merck KGaA (EMD) Missouri state 2001 $12,298,727 tax credit/rebate
Merck Sharp & Dohme Corp. Merck North Carolina state 2015 $12,098,272 tax credit/rebate
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Novartis United States federal 2017 $12,060,156 federal grant
Incyte Corporation Incyte Corp. Delaware state 2012 $11,120,505 grant/loan hybrid program
CHIRON CORPORATION Novartis United States federal 2000 $11,094,599 federal grant
Novartis #3 Novartis New Jersey state 2006 $11,060,671 Tax credit/rebate
CHIRON CORPORATION Novartis United States federal 2004 $10,427,728 federal grant
Pfizer Pfizer New York local 2003 $10,401,000 tax credit/rebate; property tax abatement
Merck, Sharp & Dohme Corp. Merck Pennsylvania state 2012 $10,263,039 tax credit/rebate
Mallinckrodt Enterprises, LLC Mallinckrodt New Jersey state 2016 $10,212,500 tax credit/rebate
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals New York state 2015 $10,200,000 tax credit/rebate
CELGENE CORPORATION Celgene United States federal 2010 $10,061,240 federal grant
SHIRE BIOLOGICS INC Takeda Pharmaceutical United States federal 2004 $9,500,092 federal grant
ACAMBIS INC Sanofi United States federal 2005 $9,284,386 federal grant
ACAMBIS INC Sanofi United States federal 2003 $9,241,818 federal grant
Pfizer Inc. Pfizer New Jersey state 2010 $9,182,250 grant
Sandoz Inc. Novartis New Jersey state 2014 $9,180,000 tax credit/rebate
Bausch & Lomb Incorporated Bausch Health New York state 2015 $9,000,000 tax credit/rebate
Vertex Pharmaceuticals Vertex Pharmaceuticals Massachusetts local 2015 $9,000,000 tax increment financing
Pharmacia Corporation, Affiliates and Subsidiaries Pfizer New Jersey state 2001 $8,752,000 grant
GlaxoSmithkline Holdings Americas , Inc. GlaxoSmithKline North Carolina state 2015 $8,524,608 tax credit/rebate
CHIMERIX INC Chimerix United States federal 2005 $8,477,202 federal grant
Sanofi-Aventis U.S. LLC and Sanofi-Aventis U.S. Sanofi New Jersey state 2005 $8,369,000 grant
King Pharmaceuticals, Inc. Pfizer New Jersey state 2005 $8,253,750 grant
Novartis Vaccines & Diagnostics Novartis North Carolina state 2006 $8,015,000 grant
MedImmune Inc. AstraZeneca Maryland state 2006 $7,500,000 grant/loan hybrid program
CHIMERIX INC Chimerix United States federal 2004 $7,492,027 federal grant
CELGENE CORPORATION Celgene United States federal 2012 $7,489,743 federal grant
WYETH PHARMACEUTICALS INC Pfizer United States federal 2003 $7,271,925 federal grant
Novartis Vaccines & Diagnostics, Inc. Novartis North Carolina state 2015 $7,125,021 tax credit/rebate
Johnson & Johnson Vision Care, Inc. Johnson & Johnson Florida local 2016 $7,100,000 grant
AMYRIS, INC. Amyris United States federal 2016 $7,000,000 federal grant
Kite Pharma, Inc. Gilead Sciences California state 2016 $7,000,000 tax credit/rebate
AMYRIS, INC. Amyris United States federal 2018 $7,000,000 federal grant
AMYRIS, INC. Amyris United States federal 2019 $7,000,000 federal grant
Novartis Vaccines & Diagnostics, Inc. Novartis North Carolina state 2011 $6,896,304 tax credit/rebate
CHIRON CORPORATION Novartis United States federal 2005 $6,884,362 federal grant
AMYRIS, INC. Amyris United States federal 2018 $6,825,720 federal grant
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals New York state 2015 $6,700,000 tax credit/rebate
Merck & Co., Inc. Merck North Carolina state 2012 $6,651,352 tax credit/rebate
WYETH PHARMACEUTICALS INC Pfizer United States federal 2005 $6,364,931 federal grant
Biogen Idec Biogen Idec Massachusetts state 2014 $6,250,000 tax credit/rebate
Teva Branded Pharmaceutical Products R&D, Inc. Teva Pharmaceutical Industries Pennsylvania state 2014 $6,118,950 tax credit/rebate
Celgene Corporation Celgene New Jersey state 2004 $6,086,250 grant
Merck & Co., Inc. Merck North Carolina state 2010 $6,007,498 tax credit/rebate
NewLink Genetics, Inc. NewLink Genetics Corp. Iowa state 2004 $6,000,000 grant
Shire HGT, Inc. Takeda Pharmaceutical Massachusetts state 2011 $5,855,368 tax credit/rebate
Novartis Pharmaceuticals Corporation ("NPC") Novartis New Jersey state 2004 $5,822,250 grant
Janssen Research & Development, LLC Johnson & Johnson Pennsylvania state 2016 $5,695,092 tax credit/rebate
Albany Molecular Research, Inc. Albany Molecular Research Inc. (AMRI) New York state 2003 $5,679,250 enterprise zone
WYETH Pfizer United States federal 2005 $5,636,276 federal grant
Aralez Pharmaceuticals US, Inc. Aralez Pharmaceuticals New Jersey state 2016 $5,625,000 tax credit/rebate
Merck Sharp & Dohme Corp. Merck North Carolina state 2004 $5,514,655 grant
Biogen Idec MA, Inc. Biogen Idec Massachusetts state 2013 $5,512,500 tax credit/rebate
Pfizer, Inc. Pfizer New York local 2007 $5,510,432 tax credit/rebate; property tax abatement
Teva Branded Pharmaceutical Products R&D, Inc. Teva Pharmaceutical Industries Pennsylvania state 2013 $5,485,485 tax credit/rebate
Janssen Research & Development, LLC ( f/k/a J&J Pharmaceutical Research & Development, LLC) Johnson & Johnson Pennsylvania state 2012 $5,461,142 tax credit/rebate
Novo Nordisk, Inc. Novo A/S New Jersey state 2007 $5,405,932 grant
TAKEDA VACCINES, INC. Takeda Pharmaceutical United States federal 2018 $5,385,144 federal grant
Abbott Laboratories Abbott Laboratories Ohio state 2012 $5,369,069 tax credit/rebate
Boehringer Ingelheim Vetmedica, Inc. Eli Lilly Iowa state 2010 $5,275,484 tax credit/rebate
Acorda Therapeutics Acorda Therapeutics New York state 2015 $5,209,220 tax credit/rebate
Pfizer, Inc. Pfizer Pennsylvania state 2011 $5,195,497 tax credit/rebate
Eli Lilly and Company Eli Lilly Pennsylvania state 2013 $5,019,493 tax credit/rebate
WYETH PHARMACEUTICALS INC Pfizer United States federal 2005 $4,934,072 federal grant
AVENTIS PASTEUR, INC Sanofi United States federal 2004 $4,923,670 federal grant
CHIRON CORPORATION Novartis United States federal 2002 $4,920,585 federal grant
MEDIMMUNE, LLC AstraZeneca United States federal 2018 $4,893,180 federal grant
Regeneron Pharmacueticals, Inc. Regeneron Pharmaceuticals New York state 2003 $4,885,774 enterprise zone
Download results as CSV or XML